Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSonic Healthcare Ltd

Sonic Healthcare Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
20.06 AUD 0.18 ( 0.91%)
Last update at 2026-11-06T06:17:00Z
VOLUME
1696309
Market Cap
9825.45M
P/E
16.16

Momentum Score

…

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
19.81
Low
20.06
High
52 Week Price Range
17.67
Low
23.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Sonic Healthcare is a global medical diagnostics company providing pathology, radiology and laboratory services across Australia, North America and Europe, serving hospitals, clinicians and aged-care facilities. Long-term growth drivers include ageing populations and rising diagnostic testing demand, expansion of molecular and precision diagnostics, and gains from acquisitions and referral networks, which may benefit recurring revenue and scale economies.

Key risks include pressure on government and private reimbursement rates, regulatory changes across multiple jurisdictions, workforce shortages and integration risk from acquisitions, any of which could adversely affect margins and volume growth.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
19.88
Dividend Yield
5.58%
Revenue TTM
10867.37M
Revenue Per Share
21.99
Gross Profit TTM
3584.86M
Debt / Equity
0.70
ROE
7.50%
Net Debt
5186.09M
ROCE
7.67%
Diluted EPS TTM
1.23

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 824.54M 750.87M 730.65M 931.19M 2077.20M
Minority interest - -30.32M -32.71M -22.95M -54.90M
Net income 608.29M 513.60M 511.09M 684.98M 1460.57M
Selling general administrative - 4695.28M 4375.05M 3868.38M 3678.97M
Selling and marketing expenses - - 2861.28M 217.02M 206.13M
Gross profit 3028.14M 3188.24M 2330.23M 6889.25M 7735.69M
Reconciled depreciation - 815.37M 777.30M 702.93M 675.42M
Ebit 1086.40M 936.19M 882.00M 1018.21M 2157.02M
Ebitda 1955.45M 1243.78M 1659.30M 1721.14M 2832.44M
Depreciation and amortization 869.05M 307.58M 777.30M 702.93M 675.42M
Operating income 1086.40M 2920.67M 552.39M 1019.10M 2157.02M
Other operating expenses 9863.43M 6724.78M 8099.76M 3502.33M 4044.69M
Interest expense 203.30M 180.51M 151.35M 87.03M 79.82M
Tax provision - 206.94M 186.85M 223.26M 561.74M
Interest income - 21.75M 24.76M 87.03M 79.82M
Net interest income - -158.76M -126.59M -87.03M -79.82M
Income tax expense 188.22M 206.94M 186.85M 223.26M 561.74M
Total revenue 10949.84M 9645.45M 8934.20M 8168.95M 9340.15M
Total operating expenses 1941.73M 267.56M 249.79M 5871.04M 5578.67M
Cost of revenue 7921.70M 6457.21M 6603.97M 1279.69M 1604.46M
Total other income expense net -261.87M -2169.81M 178.26M 10.33M 17.92M
Net income from continuing ops - 543.92M 543.80M 707.93M 1515.47M
Net income applicable to common shares - 513.60M 511.09M 684.98M 1460.57M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 16780.64M 16053.92M 14826.47M 13014.63M 12552.01M
Intangible assets - 728.46M - 7789.62M 7361.49M
Other current assets 151.32M - 136.99M 113.80M 92.26M
Total liab 8287.34M 7580.70M 6751.35M 5092.77M 5123.84M
Total stockholder equity 8338.75M 8323.50M 7917.62M 7736.50M 7273.14M
Other current liab 691.20M 20.95M 393.18M 8.23M 21.37M
Common stock 4517.89M - 4140.91M 3842.42M 3860.95M
Capital stock - 4142.01M - 3842.42M 3860.95M
Retained earnings 3627.81M 3544.11M 3552.28M 3554.20M 3351.02M
Other liab - - - 460.74M 368.69M
Good will - 9038.20M - 7237.43M 6852.96M
Other assets - - - 80.19M 259.75M
Cash 653.70M 673.77M 645.00M 797.99M 780.00M
Total current liabilities 2622.94M 2223.40M 2322.19M 1878.34M 2084.27M
Current deferred revenue - - 27.49M 563.33M 702.50M
Net debt 5186.09M 2815.45M 3870.37M 2302.49M 2232.74M
Short term debt 742.33M - 661.03M 346.79M 341.86M
Short long term debt - 80.79M - - -
Short long term debt total 5839.79M - 4515.37M 3100.48M 3012.74M
Other stockholder equity 3.27M - 3.27M -7396.62M -7217.87M
Property plant equipment - - - 2798.11M 2624.86M
Total current assets 2601.32M 2605.63M 2352.99M 2133.17M 2305.91M
Long term investments - 231.11M - 175.80M 145.22M
Net tangible assets - - - -53.12M -88.35M
Net receivables 1545.19M 1336.53M 1362.17M 1022.17M 1217.46M
Long term debt - 3408.43M - 1673.46M 1576.93M
Inventory 251.12M 226.98M 208.83M 199.20M 216.19M
Accounts payable 1189.42M 446.57M 1240.49M 959.99M 1018.55M
Accumulated other comprehensive income 189.78M - 221.16M 339.88M 61.17M
Non currrent assets other 11.26M 10.25M 8.81M 45.56M 45.54M
Non current assets total 14179.31M 13448.29M 12473.48M 10881.46M 10246.10M
Capital lease obligations - 1681.59M - 1427.02M 1435.80M
Long term debt total - - - 2753.69M 2670.88M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -577.62M -1805.44M -580.04M -81.21M
Change to liabilities - - - -75.55M 17.29M
Total cashflows from investing activities -896.99M -577.62M -1805.44M -580.04M -989.18M
Net borrowings - 242.92M 1347.09M -374.31M -624.69M
Total cash from financing activities -511.96M -735.93M 592.41M -911.51M -1349.29M
Change to operating activities - - - 9.74M -41.81M
Net income 608.29M 513.60M 511.09M 684.98M 1460.57M
Change in cash -20.08M 28.77M -152.99M 18.00M -119.83M
Begin period cash flow 673.77M 645.00M 797.99M 780.00M 899.83M
End period cash flow 653.70M 673.77M 645.00M 797.99M 780.00M
Total cash from operating activities 1405.45M 1296.79M 1071.51M 1471.03M 2225.82M
Issuance of capital stock - -0.01M 204.41M 84.27M 48.81M
Depreciation 869.05M 815.37M 777.30M 632.83M 675.42M
Other cashflows from investing activities 464.04M -146.80M 51.42M -83.03M -610.59M
Dividends paid 533.78M -514.03M -499.41M -490.53M 470.87M
Change to inventory - -4.51M -0.02M 27.46M 9.88M
Change to account receivables - -66.94M -207.84M 244.26M -83.02M
Sale purchase of stock -0.31M -0.01M -10.00M -130.93M -302.55M
Other cashflows from financing activities -453.15M -52.56M -449.68M -255.09M -206.65M
Change to netincome - - - 42.41M 2225.82M
Capital expenditures 630.74M 336.24M 579.50M 497.01M 378.59M
Change in working capital - -90.27M -208.70M 271.72M 1.99M
Stock based compensation - 22.54M 27.03M 18.45M 17.24M
Other non cash items -71.89M 35.56M -8.18M 153.22M -2135.98M
Free cash flow 774.71M 960.55M 492.01M 974.02M 1847.23M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SHL
Sonic Healthcare Ltd		 0.18
0.91%		 20.06 16.16 17.21 0.90 1.15 1.36 8.10
IDX
Integral Diagnostics Ltd		 0.01
0.58%		 1.74 28.83 15.24 0.82 0.97 1.52 9.49
ACL
Australian Clinical Labs Ltd		 0.04
1.25%		 3.24 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd		 0.01
1.01%		 0.50 - 29.24 0.26 2.08 0.94 10.14
MVF
Monash Ivf Group Ltd		 -
-%		 0.74 37.00 16.21 1.07 1.17 1.79 11.73

Profile*

Sonic Healthcare Ltd

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Grosvenor Place, Sydney, NSW, Australia, 2000

61 2 9855 5444

https://www.sonichealthcare.com

47000

Name Title Year Born
Dr. Colin Stephen Goldschmidt F.A.I.C.D., F.R.C.P.A., M.B.B.Ch. CEO, MD & Exec. Director 1954
Mr. Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. Fin. Director, CFO & Exec. Director 1958
Mr. Peter Savage Chief Bus. Officer NA
Dr. Stephen Fairy Global Chief Medical Officer NA
Mr. David Byrne Chief Exec. Officer of The Doctors Laboratory 1959
Mr. Paul J. Alexander B.Ec., C.A., F.Fin Deputy CFO & Company Sec. 1966
Mrs. G. Schottdorf Chief Exec. Officer of Schottdorf Group NA
Dr. Julian Adler Chief Exec. Officer of Sonic Imaging NA
Prashan Kulasekera Assistant Company Sec. 1972
Mr. David Byrne Chief Executive Officer of The Doctors Laboratory 1959

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…